These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 37332031)

  • 21. Carcinogenic health outcomes associated with endocrine disrupting chemicals exposure in humans: A wide-scope analysis.
    Zeng B; Wu Y; Huang Y; Colucci M; Bancaro N; Maddalena M; Valdata A; Xiong X; Su X; Zhou X; Zhang Z; Jin Y; Huang W; Bai J; Zeng Y; Zou X; Zhan Y; Deng L; Wei Q; Yang L; Alimonti A; Qi F; Qiu S
    J Hazard Mater; 2024 Sep; 476():135067. PubMed ID: 38964039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical epidemiology studies on potential effects of endocrine disrupting chemicals (EDCs) should exclude subjects with obesity as determined by BMI.
    Smith CJ; Perfetti TA; Hayes AW; Berry SC
    Regul Toxicol Pharmacol; 2020 Aug; 115():104711. PubMed ID: 32598900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated Approach to Evaluate the Association between Exposure to Pesticides and Idiopathic Premature Thelarche in Girls: The PEACH Project.
    Coppola L; Tait S; Ciferri L; Frustagli G; Merola C; Perugini M; Fabbrizi E; La Rocca C
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicological characteristics of endocrine-disrupting chemicals: developmental toxicity, carcinogenicity, and mutagenicity.
    Choi SM; Yoo SD; Lee BM
    J Toxicol Environ Health B Crit Rev; 2004; 7(1):1-24. PubMed ID: 14681080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Firm human evidence on harms of endocrine-disrupting chemicals was unlikely to be obtainable for methodological reasons.
    Lee DH; Jacobs DR
    J Clin Epidemiol; 2019 Mar; 107():107-115. PubMed ID: 30543909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thresholds of adversity for endocrine disrupting substances: a conceptual case study.
    Choi J; Rotter S; Ritz V; Kneuer C; Marx-Stoelting P; de Lourdes Marzo Solano M; Oertel A; Rudzok S; Ziková-Kloas A; Tralau T; Hensel A
    Arch Toxicol; 2024 Jul; 98(7):2019-2045. PubMed ID: 38704806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
    Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
    Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable polymers and their nano-composites for the removal of endocrine-disrupting chemicals (EDCs) from wastewater: A review.
    Al Sharabati M; Abokwiek R; Al-Othman A; Tawalbeh M; Karaman C; Orooji Y; Karimi F
    Environ Res; 2021 Nov; 202():111694. PubMed ID: 34274334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocrine disrupting chemicals and disease susceptibility.
    Schug TT; Janesick A; Blumberg B; Heindel JJ
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):204-15. PubMed ID: 21899826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of endocrine disrupting compounds on female fertility.
    Panagopoulos P; Mavrogianni D; Christodoulaki C; Drakaki E; Chrelias G; Panagiotopoulos D; Potiris A; Drakakis P; Stavros S
    Best Pract Res Clin Obstet Gynaecol; 2023 Jun; 88():102347. PubMed ID: 37244786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of perinatal exposure to endocrine-disrupting chemicals on the reproductive system of F3 generation male rodents: a meta-analysis.
    He H; Chen W; Wei Y; Zhang T; Geng W; Zhai J
    Environ Sci Pollut Res Int; 2022 May; 29(22):33218-33229. PubMed ID: 35022983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endocrine-Disrupting Chemicals and Disorders of Penile Development in Humans.
    Gaspari L; Tessier B; Paris F; Bergougnoux A; Hamamah S; Sultan C; Kalfa N
    Sex Dev; 2021; 15(1-3):213-228. PubMed ID: 34438394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endocrine-disrupting chemicals and risk of diabetes: an evidence-based review.
    Lind PM; Lind L
    Diabetologia; 2018 Jul; 61(7):1495-1502. PubMed ID: 29744538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selected endocrine disrupting compounds (vinclozolin, flutamide, ketoconazole and dicofol): effects on survival, occurrence of males, growth, molting and reproduction of Daphnia magna.
    Haeba MH; Hilscherová K; Mazurová E; Bláha L
    Environ Sci Pollut Res Int; 2008 May; 15(3):222-7. PubMed ID: 18504841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Water a major source of endocrine-disrupting chemicals: An overview on the occurrence, implications on human health and bioremediation strategies.
    Thacharodi A; Hassan S; Hegde TA; Thacharodi DD; Brindhadevi K; Pugazhendhi A
    Environ Res; 2023 Aug; 231(Pt 1):116097. PubMed ID: 37182827
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular consequences of the exposure to toxic substances for the endocrine system of females.
    Kowalczyk A; Wrzecińska M; Czerniawska-Piątkowska E; Araújo JP; Cwynar P
    Biomed Pharmacother; 2022 Nov; 155():113730. PubMed ID: 36152416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
    Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
    Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human exposure to endocrine disrupting chemicals: effects on the male and female reproductive systems.
    Sifakis S; Androutsopoulos VP; Tsatsakis AM; Spandidos DA
    Environ Toxicol Pharmacol; 2017 Apr; 51():56-70. PubMed ID: 28292651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.